Laboratory Operations At Diagnostic Sampling Tool Manufacturer Qiagen NV

Employees package Qiagen QIAxcel deoxyribonucleic acid (DNA) screening kits at the manufacturing facility of Qiagen NV in Hilden, Germany, on Friday, Aug. 22, 2014. Qiagen investors are betting the busiest year for health-care deals in more than a decade will lure acquirers to one of the industry's most expensive targets. Photographer: Jasper Juinen/Bloomberg via Getty Images
Employees package Qiagen QIAxcel deoxyribonucleic acid (DNA) screening kits at the manufacturing facility of Qiagen NV in Hilden, Germany, on Friday, Aug. 22, 2014. Qiagen investors are betting the busiest year for health-care deals in more than a decade will lure acquirers to one of the industry's most expensive targets. Photographer: Jasper Juinen/Bloomberg via Getty Images
Laboratory Operations At Diagnostic Sampling Tool Manufacturer Qiagen NV
LICENTIE KOPEN
Hoe mag ik dit beeld gebruiken?
€ 475,00
EUR

GEGEVENS

Beperkingen:
Neem voor gebruik voor alle commerciële of promotiedoeleinden contact op met uw lokale kantoor.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credits:
Bloomberg / Contributor
Redactioneel nr.:
453958802
Collectie:
Bloomberg
Gemaakt op:
22 augustus 2014
Datum van uploaden:
Soort licentie:
Rights managed
Release-informatie:
Geen release. Meer informatie
Bron:
Bloomberg
Naam materiaal:
GERMANY QIAGEN